These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11871408)

  • 1. Hepatitis C as an opportunistic infection in HIV patients.
    Clarke B
    Lancet Infect Dis; 2001 Aug; 1(1):3. PubMed ID: 11871408
    [No Abstract]   [Full Text] [Related]  

  • 2. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral therapy. Immune restoration disease in HIV-infected patients on HAART.
    French MA
    AIDS Read; 1999 Nov; 9(8):548-9, 554-5, 559-62. PubMed ID: 11082733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral hepatitis in HIV infection.
    Rendina D; Mossetti G; De Filippo G
    N Engl J Med; 2007 Jul; 357(1):90-1; author reply 91. PubMed ID: 17615641
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chronic hepatitis C in HIV-infected patients receiving highly active antiretroviral therapy (HAART)].
    Halota W; Pawłowska M
    Przegl Epidemiol; 2002; 56 Suppl 5():41-5. PubMed ID: 15553071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological evidence of HIV-associated infection among HIV-1-infected adults in Botswana.
    Wester CW; Bussmann H; Moyo S; Avalos A; Gaolathe T; Ndwapi N; Essex M; MacGregor RR; Marlink RG
    Clin Infect Dis; 2006 Dec; 43(12):1612-5. PubMed ID: 17109297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Tuberculosis' after commencing antiretroviral therapy in HIV patients from countries where Mycobacterium tuberculosis infection is common.
    French MA
    AIDS; 2006 Feb; 20(3):473-4. PubMed ID: 16439889
    [No Abstract]   [Full Text] [Related]  

  • 8. Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy.
    Macías J; Melguizo I; Fernández-Rivera FJ; García-García A; Mira JA; Ramos AJ; Rivera JM; Pineda JA
    Eur J Clin Microbiol Infect Dis; 2002 Nov; 21(11):775-81. PubMed ID: 12461586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterial immune restoration disease: one symphony, two or many?
    Price P
    AIDS; 2012 Jan; 26(1):119-20. PubMed ID: 21941164
    [No Abstract]   [Full Text] [Related]  

  • 10. Coinfection with HIV and hepatitis C virus and immune restoration during HAART.
    Manfredi R
    Clin Infect Dis; 2006 Jan; 42(2):298-9. PubMed ID: 16355345
    [No Abstract]   [Full Text] [Related]  

  • 11. HAART-prolonged life of HIV-infected patients should not be shortened by hepatitis C.
    Horster S; Goebel FD
    Infection; 2004 Dec; 32(6):369-71. PubMed ID: 15597230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What do HIV-infected patients become after an opportunistic infection?
    Malafronte B; Perbost I; Pradier C; Bentz L; Dunais B; Dellamonica P
    AIDS; 2006 Jan; 20(2):309-11. PubMed ID: 16511436
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection.
    Monga HK; Rodriguez-Barradas MC; Breaux K; Khattak K; Troisi CL; Velez M; Yoffe B
    Clin Infect Dis; 2001 Jul; 33(2):240-7. PubMed ID: 11418885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iris in an HIV seropositive leprosy patient.
    Kaur V; Singh G
    Lepr Rev; 2006 Dec; 77(4):386. PubMed ID: 17343227
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immune reconstitution syndrome. A new disease in HIV-infected patients effectively treated with antiretroviral drugs].
    Stoll M; Behrens GM; Schmidt RE
    Dtsch Med Wochenschr; 2001 Sep; 126(37):1017-22. PubMed ID: 11555777
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
    Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
    AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunistic infection associated to HIV/AIDS in Nepal.
    Arijit G; Shalini C
    Med J Malaysia; 2007 Mar; 62(1):88. PubMed ID: 17682586
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.
    Rockstroh JK; Mocroft A; Soriano V; Tural C; Losso MH; Horban A; Kirk O; Phillips A; Ledergerber B; Lundgren J;
    J Infect Dis; 2005 Sep; 192(6):992-1002. PubMed ID: 16107951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune restoration disease in HIV patients: aberrant immune responses after antiretroviral therapy.
    French M; Price P
    J HIV Ther; 2002 May; 7(2):46-51. PubMed ID: 12553688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivation of retinal toxoplasmosis despite evidence of immune response to highly active antiretroviral therapy.
    Stout JE; Lai JC; Giner J; Hamilton CD
    Clin Infect Dis; 2002 Aug; 35(4):e37-9. PubMed ID: 12145740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.